Published on 20 Jul 2023 on Simply Wall St. via Yahoo Finance

There's No Escaping Conformis, Inc.'s (NASDAQ:CFMS) Muted Revenues Despite A 86% Share Price Rise

Conformis, Inc. (NASDAQ:CFMS) shareholders would be excited to see that the share price has had a great month, posting a 86% gain and recovering from prior weakness. Still, the 30-day jump doesn't change the fact that longer term shareholders have seen their stock decimated by the 69% share price drop in the last twelve months.

Even after such a large jump in price, Conformis may still look like a strong buying opportunity at present with its price-to-sales (or "P/S") ratio of 0.3x, considering almost half of all companies in the Medical Equipment industry in the United States have P/S ratios greater than 4.1x and even P/S higher than 9x aren't out of the ordinary. However, the P/S might be quite low for a reason and it requires further investigation to determine if it's justified.

View our latest analysis for Conformis